FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study
A panel of advisers to the U.S. health regulator said on Tuesday Vertex Pharmaceuticals and CRISPR Therapeutics could
2023-11-01 07:58
Kenya sickle cell: Fighting to dispel the myths around the disease
Kenyan Lea Kilenga Bey campaigns for better treatment for those who have the genetic disease.
2023-06-12 08:47